Skip to content
Just how far can we go with psychedelic medicine; could it unlock the keys to a longer life? Are compounds hiding in plain sight?

Details
Date:
11/08/2021
Start Time:
2:40 pm
End Time:
15:05

Jackie von Salm

Co-Founder and CSO, Psilera

After receiving a PhD in natural products and organic chemistry, I was drawn to industries that challenged the norm. I have worked in various fields of drug discovery from neglected and tropical disea…

Greg McKee

Chairman and CEO

Greg McKee serves as Chairman and Chief Executive Officer of Tryp Therapeutics. Tryp is leading the next wave of psychedelic drug development beyond mental health with its focus on chronic pain and o…

Najla Guthrie

CEO, KGK Science

Throughout her career, Najla Guthrie has been hailed for both her revolutionary contributions to nutritional science and her accomplishments within the nutraceutical industry. Her original research, w…

Abraham Dreazen

CEO, IMIO Life

Abraham Dreazen, CEO & Founder of Nextage Therapeutics and IMIO Life, is a creative thinker and experienced architect with knowledge of concept design and design development. He is a serial entreprene…

Ahmad Doroudian

CEO, BetterLife Pharma

Ahmad Doroudian obtained his PhD from the University of British Columbia in Pharmacokinetics and Drug Metabolism. He has over 25 years experience as the founder and CEO of pharmaceutical companies. Hi…

Sherry Boodram

CEO, PsyDelta

Dr. Sherry Boodram is the CEO and Co-Founder of CannDelta Inc., a leading regulatory and scientific cannabis and psychedelics consulting company that provides licensing expertise and strategies in ord…

Get Recordings Now!

Easily access the recordings for your favorite Wonderland sessions, allowing you to revisit the discussions and insights shared by our visionary speakers.

Buy Now